Morgan Stanley’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.64K | Hold |
2,000
| – | – | ﹤0.01% | 7352 |
|
|
2026
Q1 | $2.74K | Hold |
2,000
| – | – | ﹤0.01% | 7271 |
|
|
2025
Q4 | $2.62K | Hold |
2,000
| – | – | ﹤0.01% | 7192 |
|
|
2025
Q3 | $2.54K | Buy |
+2,000
| New | +$2.59K | ﹤0.01% | 7260 |
|
|
2025
Q2 | – | Sell |
-100
| Closed | -$146 | – | 8215 |
|
|
2025
Q1 | $146 | Buy |
+100
| New | +$177 | ﹤0.01% | 7511 |
|
|
2024
Q2 | – | Sell |
-44
| Closed | -$64 | – | 7924 |
|
|
2024
Q1 | $64 | Hold |
44
| – | – | ﹤0.01% | 7436 |
|
|
2023
Q4 | $66 | Sell |
44
-6,169
| -99% | -$11.2K | ﹤0.01% | 7409 |
|
|
2023
Q3 | $13K | Sell |
6,213
-5,433
| -47% | -$12.6K | ﹤0.01% | 6637 |
|
|
2023
Q2 | $26.8K | Hold |
11,646
| – | – | ﹤0.01% | 6458 |
|
|
2023
Q1 | $25.2K | Sell |
11,646
-10,874
| -48% | -$24.9K | ﹤0.01% | 6545 |
|
|
2022
Q4 | $46.2K | Buy |
22,520
+10,852
| +93% | +$24K | ﹤0.01% | 6327 |
|
|
2022
Q3 | $25K | Sell |
11,668
-3,663
| -24% | -$8.48K | ﹤0.01% | 6690 |
|
|
2022
Q2 | $38K | Sell |
15,331
-49
| -0.3% | -$128 | ﹤0.01% | 6728 |
|
|
2022
Q1 | $41K | Sell |
15,380
-6,061
| -28% | -$14.8K | ﹤0.01% | 6794 |
|
|
2021
Q4 | $57K | Sell |
21,441
-11,071
| -34% | -$37K | ﹤0.01% | 6751 |
|
|
2021
Q3 | $123K | Sell |
32,512
-26,065
| -44% | -$99K | ﹤0.01% | 6254 |
|
|
2021
Q2 | $249K | Buy |
58,577
+54,984
| +1,530% | +$237K | ﹤0.01% | 5900 |
|
|
2021
Q1 | $18K | Sell |
3,593
-34,655
| -91% | -$202K | ﹤0.01% | 6759 |
|
|
2020
Q4 | $201K | Buy |
38,248
+32,604
| +578% | +$187K | ﹤0.01% | 5590 |
|
|
2020
Q3 | $30K | Sell |
5,644
-8,478
| -60% | -$48.9K | ﹤0.01% | 5906 |
|
|
2020
Q2 | $77K | Sell |
14,122
-214,302
| -94% | -$1.14M | ﹤0.01% | 5518 |
|
|
2020
Q1 | $850K | Buy |
228,424
+170,648
| +295% | +$888K | ﹤0.01% | 4067 |
|
|
2019
Q4 | $390K | Buy |
57,776
+45,006
| +352% | +$338K | ﹤0.01% | 5070 |
|
|
2019
Q3 | $102K | Buy |
12,770
+7,598
| +147% | +$67.7K | ﹤0.01% | 5440 |
|
|
2019
Q2 | $50K | Sell |
5,172
-5,869
| -53% | -$61.9K | ﹤0.01% | 5604 |
|
|
2019
Q1 | $92K | Sell |
11,041
-75,660
| -87% | -$660K | ﹤0.01% | 5422 |
|
|
2018
Q4 | $708K | Sell |
86,701
-4,180
| -5% | -$41.7K | ﹤0.01% | 4554 |
|
|
2018
Q3 | $1.14M | Buy |
90,881
+5,832
| +7% | +$58.6K | ﹤0.01% | 4437 |
|
|
2018
Q2 | $677K | Sell |
85,049
-73
| -0.1% | -$755 | ﹤0.01% | 4891 |
|
|
2018
Q1 | $871K | Sell |
85,122
-1,466
| -2% | -$14.6K | ﹤0.01% | 4640 |
|
|
2017
Q4 | $560K | Buy |
86,588
+43,135
| +99% | +$286K | ﹤0.01% | 4912 |
|
|
2017
Q3 | $276K | Buy |
43,453
+10,773
| +33% | +$57.3K | ﹤0.01% | 5194 |
|
|
2017
Q2 | $172K | Sell |
32,680
-7,106
| -18% | -$39.8K | ﹤0.01% | 5414 |
|
|
2017
Q1 | $238K | Sell |
39,786
-47,185
| -54% | -$284K | ﹤0.01% | 5242 |
|
|
2016
Q4 | $524K | Buy |
86,971
+81,003
| +1,357% | +$571K | ﹤0.01% | 4905 |
|
|
2016
Q3 | $45K | Buy |
5,968
+2,923
| +96% | +$19.7K | ﹤0.01% | 5626 |
|
|
2016
Q2 | $23K | Buy |
3,045
+1,591
| +109% | +$11.5K | ﹤0.01% | 5801 |
|
|
2016
Q1 | $11K | Buy |
1,454
+915
| +170% | +$4.53K | ﹤0.01% | 6108 |
|
|
2015
Q4 | $2K | Sell |
539
-9,770
| -95% | -$31K | ﹤0.01% | 6507 |
|
|
2015
Q3 | $29K | Buy |
10,309
+5,975
| +138% | +$20.4K | ﹤0.01% | 5923 |
|
|
2015
Q2 | $17K | Sell |
4,334
-36,917
| -89% | -$146K | ﹤0.01% | 6175 |
|
|
2015
Q1 | $144K | Sell |
41,251
-998
| -2% | -$3.55K | ﹤0.01% | 5366 |
|
|
2014
Q4 | $128K | Buy |
42,249
+42,108
| +29,864% | +$143K | ﹤0.01% | 5442 |
|
|
2014
Q3 | $0 | Buy |
141
+3
| +2% | +$7 | ﹤0.01% | 6623 |
|
|
2014
Q2 | $0 | Hold |
138
| – | – | ﹤0.01% | 6563 |
|
|
2014
Q1 | $0 | Buy |
138
+38
| +38% | +$85 | ﹤0.01% | 6512 |
|
|
2013
Q4 | $0 | Buy |
+100
| New | +$236 | ﹤0.01% | 6366 |
|
Other funds holding MNOV
EWM
Morgan Stanley's MNOV Position: Q2 2026 in Review
Morgan Stanley held its MediciNova (MNOV) position steady in Q2 2026 at 2,000 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #7352.
Morgan Stanley first reported a position in MNOV in Q4 2013 and has held it in 47 quarters since. The position peaked at $1.14M in Q3 2018. 29 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.
- Morgan Stanley held 2,000 shares of MediciNova worth $2.64K as of Q2 2026.
- Morgan Stanley left its MediciNova share count unchanged in Q2 2026.
- MediciNova made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7352 holding.
- Morgan Stanley first reported a position in MediciNova in Q4 2013 and has held it in 47 quarters since.
- Morgan Stanley's MediciNova position peaked at $1.14M in Q3 2018.
- 29 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.